Age and apoE associations with complex pathologic features in Alzheimer's disease

[1]  A. Arshad,et al.  STATINS, INCIDENT ALZHEIMER DISEASE, CHANGE IN COGNITIVE FUNCTION, AND NEUROPATHOLOGY , 2008, Neurology.

[2]  K. Jellinger.  Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia , 2008, Neurodegenerative Diseases.

[3]  I. Alafuzoff,et al.  Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance , 2008, Acta Neuropathologica.

[4]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[5]  J. Schneider,et al.  Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.

[6]  D. Dickson,et al.  Increased Frequency of Argyrophilic Grain Disease in Alzheimer Disease with 4R Tau-Specific Immunohistochemistry , 2005, Journal of neuropathology and experimental neurology.

[7]  C. Napoli,et al.  Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis , 2005, Neurobiology of Aging.

[8]  O. Lopez,et al.  Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease , 2005, Neurology.

[9]  I. Alafuzoff,et al.  α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.

[10]  R. Weller,et al.  Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy. , 2004, Panminerva medica.

[11]  M. Tolnay,et al.  Argyrophilic grain disease: A late‐onset dementia with distinctive features among tauopathies , 2004, Neuropathology : official journal of the Japanese Society of Neuropathology.

[12]  Paul G. Ince,et al.  Vascular pathologies and cognition in a population-based cohort of elderly people , 2004, Journal of the Neurological Sciences.

[13]  H. Engelberg.  Pathogenic Factors in Vascular Dementia and Alzheimer’s Disease , 2004, Dementia and Geriatric Cognitive Disorders.

[14]  S. Murayama,et al.  Staging of Argyrophilic Grains: An Age‐Associated Tauopathy , 2004, Journal of neuropathology and experimental neurology.

[15]  J. C. de la Torre,et al.  Alzheimer's disease is a vasocognopathy: a new term to describe its nature , 2004, Neurological research.

[16]  S. Murayama,et al.  Lewy Body‐Related α‐Synucleinopathy in Aging , 2004 .

[17]  J. C. Torre.  Alzheimer's disease is a vasocognopathy: a new term to describe its nature. , 2004 .

[18]  Eric M Isselbacher,et al.  Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. , 2004, Circulation.

[19]  Eric J Topol,et al.  Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins , 2004, The Lancet.

[20]  K. Jellinger.  Lewy body-related α-synucleinopathy in the aged human brain , 2004, Journal of Neural Transmission.

[21]  S. Humphries,et al.  Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches , 2004, The Lancet Neurology.

[22]  T. Iwaki,et al.  Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study , 2003, Acta Neuropathologica.

[23]  T. Iwatsubo,et al.  Accumulation of Phosphorylated α‐Synuclein in Aging Human Brain , 2003 .

[24]  R. Sulkava,et al.  Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older , 2003, Journal of neurology, neurosurgery, and psychiatry.

[25]  David S Knopman,et al.  Vascular dementia in a population-based autopsy study. , 2003, Archives of neurology.

[26]  F. Mastaglia,et al.  Prevalence of cerebral vascular amyloid-β deposition and stroke in an aging Australian population: a postmortem study , 2003, Journal of Clinical Neuroscience.

[27]  E. Tangalos,et al.  Mild cognitive impairment in the oldest old , 2003, Neurology.

[28]  V. Feigin,et al.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century , 2003, The Lancet Neurology.

[29]  Masahito Yamada,et al.  Risk Factors for Cerebral Amyloid Angiopathy in the Elderly , 2002, Annals of the New York Academy of Sciences.

[30]  Gabriel Gold,et al.  Mixed Dementia: Epidemiology, Diagnosis, and Treatment , 2002, Journal of the American Geriatrics Society.

[31]  D. Dickson,et al.  Argyrophilic Grain Disease Is a Sporadic 4‐Repeat Tauopathy , 2002, Journal of neuropathology and experimental neurology.

[32]  W. Kukull,et al.  Dementia epidemiology. , 2002, The Medical clinics of North America.

[33]  Lars-Olof Wahlund,et al.  Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains , 2002, Dementia and Geriatric Cognitive Disorders.

[34]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[35]  J. Morris,et al.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease , 2001, Journal of Molecular Neuroscience.

[36]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[37]  B. Winblad,et al.  Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project , 2000, Neurology.

[38]  Linda Teri,et al.  Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.

[39]  Elisabet Englund,et al.  Neuropathology of White Matter Changes in Alzheimer’s Disease and Vascular Dementia , 1998, Dementia and Geriatric Cognitive Disorders.

[40]  C. Brayne,et al.  Vascular Risks and Incident Dementia: Results from a Cohort Study of the Very Old , 1998, Dementia and Geriatric Cognitive Disorders.

[41]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[42]  G C Roman,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[43]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[44]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[45]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[46]  L. Thal,et al.  The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.

[47]  C. Kawas,et al.  Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging , 1996, Neurobiology of Aging.

[48]  R. Mohs,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). , 1995, Neurology.

[49]  D. F. Brown,et al.  Neuropathologic Evidence that the Lewy Body Variant of Alzheimer Disease Represents Coexistence of Alzheimer Disease and Idiopathic Parkinson Disease , 1995, Journal of neuropathology and experimental neurology.

[50]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[51]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.

[52]  L. R. Hill,et al.  The apolipoprotein E allele epsi;4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease , 1994, Neurology.

[53]  R. Levy,et al.  The Lewy-Body Variant of Alzheimer's Disease , 1993, British Journal of Psychiatry.

[54]  E. Tangalos,et al.  Mayo Clinic Alzheimer’s Disease Patient Registry , 1990, Aging.

[55]  M. Alexianu,et al.  The importance of cerebral lesions of vascular origin in the morphopathologic picture of old age dementia. , 1989, Neurologie et psychiatrie.

[56]  H. Braak,et al.  CORTICAL AND SUBCORTICAL ARGYROPHILIC GRAINS CHARACTERIZE A DISEASE ASSOCIATED WITH ADULT ONSET DEMENTIA , 1989, Neuropathology and applied neurobiology.

[57]  C. Filley.  Diagnosis of Alzheimer's disease. , 1988, Colorado medicine.

[58]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[59]  J. Wesson Ashford,et al.  APOE genotype effects on alzheimer’s disease onset and epidemiology , 2007, Journal of Molecular Neuroscience.

[60]  P. Hof,et al.  Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience , 2006, Acta Neuropathologica.

[61]  P. Box.  α-synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005 .

[62]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[63]  S. Murayama,et al.  Lewy body-related alpha-synucleinopathy in aging. , 2004, Journal of neuropathology and experimental neurology.

[64]  K. Jellinger.  Lewy body-related alpha-synucleinopathy in the aged human brain. , 2004, Journal of neural transmission.

[65]  Hideo Fujiwara,et al.  Accumulation of phosphorylated alpha-synuclein in aging human brain. , 2003, Journal of neuropathology and experimental neurology.

[66]  K. Jellinger,et al.  Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. , 2002, Neurology.

[67]  C. Duyckaerts,et al.  Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology. , 2002, Journal of neurology.

[68]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.